Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony T Newall

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Health Economics|January 26, 2016
Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological FrameworksVirginia Wiseman, Craig Mitton, Mary M Doyle-Waters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2021
Rotavirus Vaccination Likely to Be Cost Saving to Society in the United StatesAnthony T Newall, Robert Neil Leong, Josephine F Reyes, et al.
Plos One|May 31, 2014
Inaccurate ascertainment of morbidity and mortality due to influenza in administrative databases: a population-based record linkage studyDavid J Muscatello, Janaki Amin, C Raina MacIntyre, et al.
Journal of the Pediatric Infectious Diseases Society|May 31, 2022
Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Medically At-Risk Children in Australia: A Record Linkage StudyAlamgir Kabir, Anthony T Newall, Deborah Randall, et al.
Vaccine|July 28, 2023
Incremental effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia hospitalisation among Australian Indigenous children: A record linkage studyAlamgir Kabir, Deborah Randall, Anthony T Newall, et al.
Vaccine|May 3, 2026
Respiratory syncytial virus (RSV) vaccination program for older Australians reduces health inequalities: a distributional cost-effectiveness analysisKishor K Paul, Monica Torres, Sophy T F Shih, et al.
Vaccine|April 19, 2026
Estimating the cost-effectiveness of respiratory syncytial virus (RSV) vaccination program for older Australian adultsKishor K Paul, Monica Torres, Sophy T F Shih, et al.
Vaccine|February 24, 2021
Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkageAlamgir Kabir, Anthony T Newall, Deborah Randall, et al.
Vaccine|February 25, 2026
Unequal access: Respiratory syncytial virus vaccine uptake by socioeconomic status among older adults in AustraliaDavid C Boettiger, Sandra J Carlson, Stuart R Adams, et al.
Vaccine|November 27, 2019
Financial cost analysis of a strategy to improve the quality of administrative vaccination data in UgandaKirsten Ward, Kevin Mugenyi, Adam MacNeil, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Health Economics|January 26, 2016
Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological FrameworksVirginia Wiseman, Craig Mitton, Mary M Doyle-Waters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2021
Rotavirus Vaccination Likely to Be Cost Saving to Society in the United StatesAnthony T Newall, Robert Neil Leong, Josephine F Reyes, et al.
Plos One|May 31, 2014
Inaccurate ascertainment of morbidity and mortality due to influenza in administrative databases: a population-based record linkage studyDavid J Muscatello, Janaki Amin, C Raina MacIntyre, et al.
Journal of the Pediatric Infectious Diseases Society|May 31, 2022
Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Medically At-Risk Children in Australia: A Record Linkage StudyAlamgir Kabir, Anthony T Newall, Deborah Randall, et al.
Vaccine|July 28, 2023
Incremental effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia hospitalisation among Australian Indigenous children: A record linkage studyAlamgir Kabir, Deborah Randall, Anthony T Newall, et al.
Vaccine|May 3, 2026
Respiratory syncytial virus (RSV) vaccination program for older Australians reduces health inequalities: a distributional cost-effectiveness analysisKishor K Paul, Monica Torres, Sophy T F Shih, et al.
Vaccine|April 19, 2026
Estimating the cost-effectiveness of respiratory syncytial virus (RSV) vaccination program for older Australian adultsKishor K Paul, Monica Torres, Sophy T F Shih, et al.
Vaccine|February 24, 2021
Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkageAlamgir Kabir, Anthony T Newall, Deborah Randall, et al.
Vaccine|February 25, 2026
Unequal access: Respiratory syncytial virus vaccine uptake by socioeconomic status among older adults in AustraliaDavid C Boettiger, Sandra J Carlson, Stuart R Adams, et al.
Vaccine|November 27, 2019
Financial cost analysis of a strategy to improve the quality of administrative vaccination data in UgandaKirsten Ward, Kevin Mugenyi, Adam MacNeil, et al.
Pageof 7